Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANA YESKE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health

NPI
1972963189
CMS profile
10701532
Location
BALTIMORE, MD

General Payments · PY2023–2024

$1,880.89

  • Reported across 34 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,033.08

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $883.10 14
Education $149.98 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $598.46 6
Astellas Pharma US Inc $149.98 2
Acerta Pharma LLC $108.12 1
BeiGene USA, Inc. $53.85 2
Daiichi Sankyo Inc. $50.55 2
Genentech USA, Inc. $26.33 1
EISAI INC. $23.97 1
NOVARTIS PHARMACEUTICALS CORPORATION $21.82 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $847.81 18
PY2024 $1,033.08 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $74.99 08/07/2024 Education Undisputed 01/23/2026 1139526518 CMS
Astellas Pharma US Inc $74.99 08/08/2024 Education Undisputed 01/23/2026 1139526520 CMS
AstraZeneca Pharmaceuticals LP $108.12 02/15/2024 Food and Beverage Undisputed 01/23/2026 1105568955 CMS
BeiGene USA, Inc. $23.50 11/21/2024 Food and Beverage Undisputed 01/23/2026 1120854585 CMS
BeiGene USA, Inc. $30.35 12/10/2024 Food and Beverage Undisputed 01/23/2026 1120854583 CMS
Daiichi Sankyo Inc. $22.52 01/25/2024 Food and Beverage Undisputed 01/23/2026 1089500692 CMS
Daiichi Sankyo Inc. $28.03 07/16/2024 Food and Beverage Undisputed 01/23/2026 1089500694 CMS
Eisai Inc. $23.97 04/10/2024 Food and Beverage Undisputed 01/23/2026 1110798993 CMS
Genentech USA, Inc. $26.33 11/13/2024 Food and Beverage Undisputed 01/23/2026 1133153245 CMS
Janssen Biotech, Inc. $133.56 01/17/2024 Food and Beverage Undisputed 01/23/2026 1078709110 CMS
Janssen Biotech, Inc. $120.84 07/11/2024 Food and Beverage Undisputed 01/23/2026 1078706895 CMS
Janssen Biotech, Inc. $62.97 09/10/2024 Food and Beverage Undisputed 01/23/2026 1078711251 CMS
Janssen Biotech, Inc. $139.92 10/17/2024 Food and Beverage Undisputed 01/23/2026 1078709997 CMS
Janssen Biotech, Inc. $19.33 11/18/2024 Food and Beverage Undisputed 01/23/2026 1078711204 CMS
Janssen Biotech, Inc. $121.84 12/12/2024 Food and Beverage Undisputed 01/23/2026 1078708759 CMS
Novartis Pharmaceuticals Corporation $21.82 04/03/2024 Food and Beverage Undisputed 01/23/2026 1087389216 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.